Adar Poonawalla has confirmed that the Serum Institute of India has applied for an emergency use authorization for the Covishield coronavirus vaccine. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorization for the first vaccine manufactured in India, COVISHIELD. This will save countless lives, and …
Read More »One day after Pfizer, Serum Institute seeks emergency use for Covishield in India citing ‘unmet’ medical needs
Coronavirus News LIVE Updates: The Serum Institute of India became the first indigenous company on Sunday to apply to the Controller General of Drugs of India (DCGI) seeking an emergency use authorization for Oxford COVID-19 vaccine in the country citing unmet medical needs due to the pandemic and in the …
Read More »Indian Coronavirus Vaccine: India Puts Hopes on 4 Covid-19 Vaccines to Inoculate Rs 30 Crore in July | India News
NEW DELHI: The government expects two Covid-19 vaccines, Covishield from Oxford-AstraZeneca and Covaxin from Bharat Biotech, to be available in January and about four vaccines by the end of April, increasing prospects for adequate supplies to inoculate a priority of Rs 30 crore. population in July, an official said. While …
Read More »IBS Seeks Emergency Use Authorization for Oxford Covid Vaccine in India
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the country citing needs. not covered due to the pandemic and in interest. from …
Read More »Serum Seeks Emergency Use Authorization for Covishield Vaccine in India
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford COVID-19 vaccine in the country citing needs not covered due to the pandemic and in the interest …
Read More »Serum Institute Requests Emergency Use Authorization for Oxford Covid-19 Covishield Vaccine in India | India News
NEW DELHI: The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the citing unmet medical needs due to the pandemic and in the …
Read More »Jabs for all versus enough shots for herd immunity
The Center says India does not need to administer COVID-19 vaccine injections to the entire population. Rather, inoculating a “critical mass” in priority will help break the chain of transmission. If the previous presumption was that everyone would be released, what does this mean? Mint delves into What does the …
Read More »Volunteer doctor blames IBS vaccine for neurological disorder
A Chennai neurologist opined that the 40-year-old man who volunteered for the Serum Institute of India’s covid vaccine trial developed acute neurological symptoms after receiving the injection. The participant had visited the doctor after being discharged from the hospital linked to the Covishield trial site. “Clusters of clinical, electrophysiological and …
Read More »Serum Institute Denies Side Effect Claims Raised By Chennai Volunteer
After a Chennai man claimed he suffered from neurological and psychological side effects after taking Covishield COVID-19 During human trials, the Serum Institute of India reaffirmed Tuesday that the Covishield vaccine is safe and immunogenic and that the company has followed all necessary regulatory and ethical processes diligently, before proceeding …
Read More »The government never spoke about vaccinating the entire country, says the health ministry
The government said Tuesday that it has not talked about vaccinating the entire population of the country against the coronavirus disease (Covid-19), as India has reported 9,462,809 infections and 137,621 related deaths so far. “I just want to make this clear that the government has never talked about vaccinating the …
Read More »